Life Science REIT (LON:LABS) Trading Down 0.5% – Time to Sell?

Life Science REIT plc (LON:LABS) shares were down 0.5% on Tuesday . The stock traded as low as GBX 36.70 ($0.46) and last traded at GBX 36.70 ($0.46). Approximately 321,672 shares changed hands during mid-day trading, a decline of 21% from the average daily volume of 409,043 shares. The stock had previously closed at GBX 36.90 ($0.46).

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on LABS shares. Berenberg Bank restated a “buy” rating and set a GBX 57 ($0.71) target price on shares of Life Science REIT in a research note on Thursday, October 3rd. Shore Capital restated a “buy” rating on shares of Life Science REIT in a report on Thursday, September 26th.

Life Science REIT Stock Down 0.5 %

The stock has a fifty day moving average price of GBX 39.32 and a two-hundred day moving average price of GBX 36.58. The company has a market cap of £128.45 million, a price-to-earnings ratio of -611.67 and a beta of 0.08.

Life Science REIT Company Profile

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.